Lijun Cheng
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
128
Citations
5,474
Est. group size
~8
Recurring co-author estimate
Active years
25
Publishing since 2002
Lijun Cheng's work focuses on using computational and genomic approaches to study cancer, including identifying gene essentiality in cancer cell death pathways, finding molecular mechanisms linking cancer to other diseases, and predicting synthetic lethality (a strategy for designing cancer drugs that kill cells only when two genes are disrupted together). The research combines bioinformatics, cancer genomics, and machine learning methods, with some publications extending into unrelated areas like image processing and agricultural technology.
Publication output has been variable over the last decade, with a notable peak in 2023 followed by a decline in 2024 and partial recovery in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Landscape of Gene Essentiality in Cancer Cell Death Pathways
Genes · 2026
- The burden of nasopharyngeal carcinoma in countries of the Association of Southeast Asian Nations (ASEAN), 1990–2023: findings from the Global Burden of Disease Study 2023
Journal of Cancer Research and Clinical Oncology · 2026
- Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical Cavity
Advanced Materials · 2025
- Investigating key genes and molecular mechanisms of prostate cancer and coronary heart disease through transcriptomics and experimental validation
Translational Andrology and Urology · 2025
- Abstract 3642: TLSL: Transfer learning for synthetic lethality (SL) experiment design and SL prediction
Cancer Research · 2025
- Hyperspectral Image Super-Resolution via Degradation-Aware Learning and Frequency-Domain Feature Enhancement
Lecture notes in computer science · 2025
- Towards urban energy sustainability and resiliency through smart agriculture and effective renewable resource allocation
Sustainable Cities and Society · 2024
- Data from Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
2023
- ResNet-based dairy daily behavior recognition
EAI Endorsed Transactions on Internet of Things · 2023
- The impact of common variants on gene expression in the human brain: from RNA to protein to schizophrenia risk
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Seq-CNN: A Lightweight and Efficient Neural Network for Sentimental Analysis of Text
2023
- Data from Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
2023
- Supplementary Table from Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
2023
- Supplementary Table from Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
2023
- Supplementary Table from Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
2023
- Cancer Research×11
- PMC×6
- Cancers×5
- Genes×5
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Min Wu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yang Huo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Hojin Yoo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kunjie Fan
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yijie Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile